This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
First US Patient Treated With Cook Medical’s Recently Approved Zenith® Dissection Endovascular System
Cook Medical announced that Dr Joseph Lombardi in New Jersey treated the first patient in the US using the newly approved Zenith® Dissection Endovascular System as part of the device's commercial launch. The system consists of a proximal stent-graft component and a distal bare stent component. “The value in this dissection stent is that it’s pathology-specific, designed just for this disease," said Dr Lombardi, the Global Principal Investigator of the STABLE I and STABLE II clinical trials.